Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (33)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Georgitis, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Georgitis, J. W.
(Chest. 1999;115:210-217.)
© 1999 American College of Chest Physicians

The 1997 Asthma Management Guidelines and Therapeutic Issues Relating to the Treatment of Asthma*

John W. Georgitis, MD, FCCP

* From the Department of Pediatrics, Division of Pediatric Allergy, Immunology, and Respiratory Medicine, Wake Forest University School of Medicine, Bowman Gray Campus, Winston-Salem, NC.

In 1997, the National Heart, Lung, and Blood Institute released the Second Expert Panel Report on the Guidelines for the Diagnosis and Management of Asthma as a follow-up to the first report issued in 1991. Implementation of the recommendations from this report could have a potentially huge impact on care and treatment of asthma in the United States. Even though the Guidelines are expansive, there are some areas related to the pharmacologic component that warrant further discussion and clarification. These are: (1) safety and efficacy of available asthma medications, (2) clinical efficacy comparisons of inhaled corticosteroids, (3) comparative risks among inhaled corticosteroids, and (4) expectations of different delivery systems used with inhaled corticosteroids.

Key Words: asthma guidelines • asthma management • inhaled corticosteroids




This article has been cited by other articles:


Home page
 Eur Respir JHome page
H. Derendorf, R. Nave, A. Drollmann, F. Cerasoli, and W. Wurst
Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma.
Eur. Respir. J., November 1, 2006; 28(5): 1042 - 1050.
[Abstract] [Full Text] [PDF]

Home page
 J Clin PharmacolHome page
S. Rohatagi, V. Arya, K. Zech, R. Nave, G. Hochhaus, B. K. Jensen, and J. S. Barrett
Population Pharmacokinetics and Pharmacodynamics of Ciclesonide
J. Clin. Pharmacol., April 1, 2003; 43(4): 365 - 378.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
F. Gallefoss and P.S. Bakke
Cost-effectiveness of self-management in asthmatics: a 1-yr follow-up randomized, controlled trial
Eur. Respir. J., February 1, 2001; 17(2): 206 - 213.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
R. B. Lipton, W. F. Stewart, A. M. Stone, M. J. A. Lainez, and J. P. C. Sawyer
Stratified Care vs Step Care Strategies for Migraine: The Disability in Strategies of Care (DISC) Study:; A Randomized Trial
JAMA, November 22, 2000; 284(20): 2599 - 2605.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
L. E. Burgess, B. J. Newhouse, P. Ibrahim, J. Rizzi, M. A. Kashem, A. Hartman, B. J. Brandhuber, C. D. Wright, D. S. Thomson, G. P. A. Vigers, et al.
Potent selective nonpeptidic inhibitors of human lung tryptase
PNAS, July 20, 1999; 96(15): 8348 - 8352.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American College of Chest Physicians.